As VP, Managing Director, Todd is responsible for financial management and business planning; overseeing team growth and staff development; and establishing and maintaining procedure, performance, and quality standards. Todd has over 15 years of medical communications agency experience overseeing scientific strategy (eg, scientific platforms, disease-state education plans, publication planning) and tactical implementation. Todd has also been involved in identifying and expanding new service offerings (ie, developing innovative approaches to address client needs). His areas of expertise include biochemistry, drug development, immunology, infectious diseases, inflammation, and oncology. Before he joined MedThink SciCom, Todd worked at a medical communications company in the Midwest, where he provided scientific direction for multiple products in the oncology space. Todd earned his PhD in Biochemistry and Molecular Biology from Mississippi State University. He completed his postdoctoral research at Ohio University studying the mechanism of action of 2 biological response modifiers. Todd is currently serving as the Chair Elect for the ISMPP Board of Trustees.